These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 12792783

  • 1. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ.
    Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
    [Abstract] [Full Text] [Related]

  • 2. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M.
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [Abstract] [Full Text] [Related]

  • 3. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS.
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N, Higuchi H, Kanamori H, Kurita S, Tada S, Takaishi H, Toda K, Yamada T, Kumagai N, Saito H, Hibi T.
    Int J Oncol; 2006 Sep 15; 29(3):625-35. PubMed ID: 16865278
    [Abstract] [Full Text] [Related]

  • 6. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC, Wang S, Zhang H, Ye YJ, Liang B, Cui ZR.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):583-6. PubMed ID: 15144595
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
    Ding XZ, Tong WG, Adrian TE.
    Anticancer Res; 2000 Apr 02; 20(4):2625-31. PubMed ID: 10953335
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep 02; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 11. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N, Foderà D, D'Alessandro N, Cusimano A, Azzolina A, Tripodo C, Florena AM, Minervini MI, Notarbartolo M, Montalto G, Cervello M.
    Int J Mol Med; 2006 Feb 02; 17(2):245-52. PubMed ID: 16391822
    [Abstract] [Full Text] [Related]

  • 12. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR.
    Mol Carcinog; 2007 Dec 02; 46(12):971-80. PubMed ID: 17477358
    [Abstract] [Full Text] [Related]

  • 13. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S, Osaki M, Honjo S, Takeda A, Adachi K, Araki K, Ito H.
    J Exp Clin Cancer Res; 2004 Jun 02; 23(2):301-7. PubMed ID: 15354416
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 15. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM.
    J Am Coll Surg; 2004 Sep 15; 199(3):428-35. PubMed ID: 15325613
    [Abstract] [Full Text] [Related]

  • 16. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Int J Mol Med; 2006 Jul 15; 18(1):41-7. PubMed ID: 16786154
    [Abstract] [Full Text] [Related]

  • 17. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J, Chen X, Dong X, Xu Z, Jiang H, Sun X.
    J Gastroenterol Hepatol; 2006 Dec 15; 21(12):1814-20. PubMed ID: 17074019
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.